Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedShares IssuedShares OutstandingShares Outstanding
Ratios

vTv Therapeutics (VTVT) Accumulated Depreciation & Amortization (2016 - 2024)

vTv Therapeutics (VTVT) has disclosed Accumulated Depreciation & Amortization for 11 consecutive years, with $508000.0 as the latest value for Q4 2024.

  • Quarterly Accumulated Depreciation & Amortization rose 4.31% to $508000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $508000.0 through Dec 2024, up 4.31% year-over-year, with the annual reading at $508000.0 for FY2024, 4.31% up from the prior year.
  • Accumulated Depreciation & Amortization hit $508000.0 in Q4 2024 for vTv Therapeutics, up from $487000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $508000.0 in Q4 2024 to a low of $216000.0 in Q4 2020.
  • Historically, Accumulated Depreciation & Amortization has averaged $382600.0 across 5 years, with a median of $397000.0 in 2022.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 45.95% in 2020 and later rose 4.31% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $216000.0 in 2020, then soared by 41.2% to $305000.0 in 2021, then soared by 30.16% to $397000.0 in 2022, then rose by 22.67% to $487000.0 in 2023, then increased by 4.31% to $508000.0 in 2024.
  • Business Quant data shows Accumulated Depreciation & Amortization for VTVT at $508000.0 in Q4 2024, $487000.0 in Q4 2023, and $397000.0 in Q4 2022.